FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202118904> ?p ?o ?g. }

• W3202118904 endingPage "1017" @default.
• W3202118904 startingPage "1017" @default.
• W3202118904 abstract "Background and objectives: Because few data are available, the aim of this study is to analyze the effects of antithrombotic agents (ATAs) on visual function and long-term risk of cardiovascular events and mortality in hypertensive patients with retinal vein occlusion (RVO). Materials and methods: Hypertensive patients with RVO were consecutively selected from 2008 to 2012 and followed for a median of 8.7 years. Ophthalmologists evaluated and treated RVO complications, and best-corrected visual acuity (BCVA) was checked at each visit during the first one year of follow-up. Survival analysis was conducted on the rate of the composite endpoint of all-cause deaths or non-fatal cardiovascular events. Results: Retrospectively, we collected data from 80 patients (age 68 ± 12 years, 39 males). Central and branch RVO was present in 41 and 39 patients, respectively, and 56 patients started ATAs (50 antiplatelet drugs, 6 warfarin, and 2 low-molecular weight heparin). Average BCVA of the cohort did not change significantly during one-year of follow-up. The only predictor of BCVA was the baseline BCVA value. There was a reduction in proportion and severity of macular edema and an increase in the cumulative proportion of retinal vein patency reestablishment during the follow-up, independent of treatment. ATAs had no effects on one-year BCVA, intraocular complications, or the composite endpoint rate. Conclusions: In this exploratory study, ATAs had no effect on BCVA during the first one year of follow-up and on the composite endpoint during the long-term follow-up. Further prospective studies need to be conducted with an accurate standardization of the intraocular and antithrombotic treatment to define the positive or negative role of ATAs in hypertensive patients with RVO." @default.
• W3202118904 created "2021-10-11" @default.
• W3202118904 creator A5003374711 @default.
• W3202118904 creator A5008140568 @default.
• W3202118904 creator A5014180438 @default.
• W3202118904 creator A5036443714 @default.
• W3202118904 creator A5036953199 @default.
• W3202118904 creator A5072360699 @default.
• W3202118904 creator A5076416164 @default.
• W3202118904 creator A5077168871 @default.
• W3202118904 creator A5082373775 @default.
• W3202118904 creator A5087143546 @default.
• W3202118904 date "2021-09-25" @default.
• W3202118904 modified "2023-09-27" @default.
• W3202118904 title "Effects of Antithrombotic Agents on Ophthalmological Outcomes, Cardiovascular Risk, and Mortality in Hypertensive Patients with Retinal Vein Occlusion: An Exploratory Retrospective Study" @default.
• W3202118904 cites W1822338637 @default.
• W3202118904 cites W185706350 @default.
• W3202118904 cites W1968746974 @default.
• W3202118904 cites W1973523238 @default.
• W3202118904 cites W1997777727 @default.
• W3202118904 cites W2000445173 @default.
• W3202118904 cites W2015847134 @default.
• W3202118904 cites W2020422464 @default.
• W3202118904 cites W2021464159 @default.
• W3202118904 cites W2021518159 @default.
• W3202118904 cites W2026459749 @default.
• W3202118904 cites W2044490764 @default.
• W3202118904 cites W2045342919 @default.
• W3202118904 cites W2048931126 @default.
• W3202118904 cites W2071074251 @default.
• W3202118904 cites W2086307461 @default.
• W3202118904 cites W2091127600 @default.
• W3202118904 cites W2107375227 @default.
• W3202118904 cites W2113236383 @default.
• W3202118904 cites W2126545176 @default.
• W3202118904 cites W2132709813 @default.
• W3202118904 cites W2134625781 @default.
• W3202118904 cites W2135540737 @default.
• W3202118904 cites W2275203427 @default.
• W3202118904 cites W2335369182 @default.
• W3202118904 cites W2546640126 @default.
• W3202118904 cites W2746351421 @default.
• W3202118904 cites W2801605983 @default.
• W3202118904 cites W2809178950 @default.
• W3202118904 cites W2889498071 @default.
• W3202118904 cites W2938439299 @default.
• W3202118904 cites W2968318784 @default.
• W3202118904 cites W2968480065 @default.
• W3202118904 cites W2998307559 @default.
• W3202118904 doi "https://doi.org/10.3390/medicina57101017" @default.
• W3202118904 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8537937" @default.
• W3202118904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34684054" @default.
• W3202118904 hasPublicationYear "2021" @default.
• W3202118904 type Work @default.
• W3202118904 sameAs 3202118904 @default.
• W3202118904 citedByCount "1" @default.
• W3202118904 countsByYear W32021189042023 @default.
• W3202118904 crossrefType "journal-article" @default.
• W3202118904 hasAuthorship W3202118904A5003374711 @default.
• W3202118904 hasAuthorship W3202118904A5008140568 @default.
• W3202118904 hasAuthorship W3202118904A5014180438 @default.
• W3202118904 hasAuthorship W3202118904A5036443714 @default.
• W3202118904 hasAuthorship W3202118904A5036953199 @default.
• W3202118904 hasAuthorship W3202118904A5072360699 @default.
• W3202118904 hasAuthorship W3202118904A5076416164 @default.
• W3202118904 hasAuthorship W3202118904A5077168871 @default.
• W3202118904 hasAuthorship W3202118904A5082373775 @default.
• W3202118904 hasAuthorship W3202118904A5087143546 @default.
• W3202118904 hasBestOaLocation W32021189041 @default.
• W3202118904 hasConcept C118487528 @default.
• W3202118904 hasConcept C126322002 @default.
• W3202118904 hasConcept C167135981 @default.
• W3202118904 hasConcept C168563851 @default.
• W3202118904 hasConcept C203092338 @default.
• W3202118904 hasConcept C2776268601 @default.
• W3202118904 hasConcept C2776301958 @default.
• W3202118904 hasConcept C2777015399 @default.
• W3202118904 hasConcept C2778257484 @default.
• W3202118904 hasConcept C2779161974 @default.
• W3202118904 hasConcept C2780347916 @default.
• W3202118904 hasConcept C2908732032 @default.
• W3202118904 hasConcept C71924100 @default.
• W3202118904 hasConcept C72563966 @default.
• W3202118904 hasConceptScore W3202118904C118487528 @default.
• W3202118904 hasConceptScore W3202118904C126322002 @default.
• W3202118904 hasConceptScore W3202118904C167135981 @default.
• W3202118904 hasConceptScore W3202118904C168563851 @default.
• W3202118904 hasConceptScore W3202118904C203092338 @default.
• W3202118904 hasConceptScore W3202118904C2776268601 @default.
• W3202118904 hasConceptScore W3202118904C2776301958 @default.
• W3202118904 hasConceptScore W3202118904C2777015399 @default.
• W3202118904 hasConceptScore W3202118904C2778257484 @default.
• W3202118904 hasConceptScore W3202118904C2779161974 @default.
• W3202118904 hasConceptScore W3202118904C2780347916 @default.
• W3202118904 hasConceptScore W3202118904C2908732032 @default.
• W3202118904 hasConceptScore W3202118904C71924100 @default.
• W3202118904 hasConceptScore W3202118904C72563966 @default.
• W3202118904 hasIssue "10" @default.

• next